Spin the roulette wheel

Gilead Sciences, Inc.(Nasdaq: GILD) announced today its results of operations for the quarter ended June 30, 2008. Total revenues for the second quarter of 2008 were $1. 28 billion, up 22 percent compared to total revenues of $1. 05 billion for the second quarter of 2007. Net income for the second quarter of 2008 was $442. 8 million, or $0. 46 per diluted share, including after-tax stock-based compensation expense of $26. 4 million and after-tax purchased in-process research and development (IPR&D) expense of $7. 8 million. Excluding after-tax stock-based compensation and IPR&D expenses of $34. 2 million, non-GAAP net income for the second quarter of 2008 was $477. 0 million, or $0. 49 per diluted share. Non-GAAP net income for the second quarter of 2007 was $442. gambling favors roulette calculator roulette strategy system gambling in the internet onlinekeno roulette bingo back-gammon-online